Green Vision Biotechnology (GVBT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access GVBT Annual Balance Sheets →
This balance sheet overview for Green Vision Biotechnology spans from Jun 30 2021 to Jun 30 2022, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2022)
(Mar 31 2022) (Dec 31 2021) (Sep 30 2021) (Jun 30 2021)
Assets
Cash & cash equivalent0.02
Cash & Short-term Investments0.00
Other Receivables0.02
Inventories0.00
Other Current Assets0.00
Total Current Assets0.04
Equipment/Property/Plant Net0.87
Intangible Assets0.76
Long-term investments0.00
Other Assets, Noncurrent0.00
Assets Held For Sale Not Part Of Disposal Group0.00
Total Assets1.68
Liabilities
Accounts Payable, Current AC0.02
Accrued Liabilities, Current0.32
Other Liabilities, Current10.32
Taxes Payable, Current, Total0.00
Customer Advances, Current0.00
Total Current Liabilities10.66
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Total Liabilities10.66
Stockholders' Equity
Common Stock Value0.16
Additional Paid In Capital Common Stock-0.28
Retained Earnings / Accumulated Deficit-8.88
Other Equity0.02
Common Stockholder's Equity-8.98
Total Stockholder's Equity-8.98
Liabilities & Stockholder's Equity1.68
4 historic quarters locked

Sign in to unlock the full Green Vision Biotechnology balance sheet history.

About Green Vision Biotechnology Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001640334-22-002058

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.